| Mogi M, Li JM, Tsukuda K, et al.
Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. [JOURNAL ARTICLE]
Biochem Biophys Res Commun 2008 Aug 17.
Abstract | Full Citation | | Berlaimont V, Billiouw JM, Brohet C, et al.
Lessons from ONTARGET. [Journal Article]
Acta Clin Belg 2008 May-Jun; 63(3):142-51.
Abstract | Full Citation | | Sharma A, Baliga V
Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study. [Journal Article]
J Indian Med Assoc 2008 Mar; 106(3):191-4, 196.
Abstract | Full Citation | | Sasaki T, Noda Y, Yasuoka Y, et al.
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome. [Journal Article]
Hypertens Res 2008 May; 31(5):921-9.
Abstract | Full Citation | | Nakamura T, Inoue T, Suzuki T, et al.
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. [Journal Article]
Hypertens Res 2008 May; 31(5):841-50.
Abstract | Full Citation | Find Related Articles | | Mann JF, Schmieder RE, McQueen M, et al.
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2008 Aug 16; 372(9638):547-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schumacher H, Mancia G
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies. [Journal Article]
Blood Press Suppl 2008 Jun.:32-40.
Abstract | Full Citation | Find Related Articles | | Dominiak M
[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59] [Comment, Journal Article]
Kardiol Pol 2008 Jun; 66(6):705-6; discussion 707.
Full Citation | Find Related Articles | | Nishiyama A, Nakagawa T, Kobori H, et al.
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. [JOURNAL ARTICLE]
J Hypertens 2008 Sep; 26(9):1849-1859.
Abstract | Full Citation | | Yamana A, Arita M, Furuta M, et al.
The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2008 Aug 8.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
